Scleroderma: Difference between revisions
Jump to navigation
Jump to search
m →See also: +sle |
m →General |
||
| Line 3: | Line 3: | ||
==General== | ==General== | ||
Clinical: | Clinical: | ||
*Anti-centromere antibody +ve. | *Anti-centromere antibody (ACA) +ve. | ||
**Common in ''limited systemic scleroderma'', [[AKA]] CREST Syndrome. | **Common in ''limited systemic scleroderma'', [[AKA]] CREST Syndrome. | ||
*Scl-70 (topoisomerase I). | *Scl-70 (topoisomerase I) +ve. | ||
**Common in ''diffuse scleroderma''. | **Common in ''diffuse scleroderma''. | ||
Revision as of 22:44, 3 December 2011
Scleroderma is a disease that keeps rheumatologists busy.
General
Clinical:
- Anti-centromere antibody (ACA) +ve.
- Common in limited systemic scleroderma, AKA CREST Syndrome.
- Scl-70 (topoisomerase I) +ve.
- Common in diffuse scleroderma.